Albert S. Kearney

The Interconversion Kinetics, Equilibrium, and Solubilities of the Lactone and Hydroxyacid Forms of the HMG-CoA Reductase Inhibitor, CI-981

Albert S. Kearney, Lee F. Crawford, Surendra C. Mehta et al. · Pharmaceutical Research · 1993 · 128 citations

Life Sciences, Biochemistry, Molecular Biology +6

Investigation of formulation approaches to improve the dissolution of SB-210661, a poorly water soluble 5-lipoxygenase inhibitor

Cherng‐Yih Perng, Albert S. Kearney, Kamlesh D. Patel et al. · International Journal of Pharmaceutics · 1998 · 46 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Buccal and oral bioavailability of naloxone and naltrexone in rats

Munir Hussain, Bruce J. Aungst, Albert S. Kearney et al. · International Journal of Pharmaceutics · 1987 · 44 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens

Cherng‐Yih Perng, Albert S. Kearney, Nagesh R. Palepu et al. · International Journal of Pharmaceutics · 2002 · 40 citations

Pharmacy, Pharmaceutical Analysis, Pharmacokinetics +14

Effect of polyvinylpyrrolidone on the crystallinity and dissolution rate of solid dispersions of the antiinflammatory CI-987

Albert S. Kearney, Dawn L. Gabriel, Surendra C. Mehta et al. · International Journal of Pharmaceutics · 1994 · 40 citations

Pharmacy, Chemistry, Materials Science +15